Public Health Manufacturing Africa May 3, 2021Vaccine manufacturing in Africa is still nascent, especially in the upstream segments of the value chain, such as antigen production and other drug-substance manufacturing processes. We strive to provide individuals with disabilities equal access to our website. If you would like information about this content we will be happy to work with you. Please email us at: McKinsey_Website_Accessibility@mckinsey.com To read the article, see “Africa needs vaccines. What would it take to make them here?,” April 14, 2021.